IRIS
GARRIBBA, Eugenio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.243
AS - Asia 6.322
SA - Sud America 3.618
EU - Europa 3.225
AF - Africa 261
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 11
Totale 24.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.989
BR - Brasile 3.217
SG - Singapore 2.661
CN - Cina 1.751
UA - Ucraina 1.154
HK - Hong Kong 592
DE - Germania 487
VN - Vietnam 418
SE - Svezia 329
FI - Finlandia 249
FR - Francia 240
IT - Italia 224
GB - Regno Unito 191
AR - Argentina 134
TR - Turchia 131
BD - Bangladesh 114
MX - Messico 111
IN - India 94
IQ - Iraq 90
CA - Canada 88
RU - Federazione Russa 75
ZA - Sudafrica 67
EC - Ecuador 63
VE - Venezuela 60
JP - Giappone 57
UZ - Uzbekistan 57
MA - Marocco 56
CO - Colombia 47
PL - Polonia 45
ID - Indonesia 43
PK - Pakistan 41
ES - Italia 38
NL - Olanda 37
KR - Corea 33
KE - Kenya 29
PY - Paraguay 28
AZ - Azerbaigian 25
JO - Giordania 24
OM - Oman 22
UY - Uruguay 22
AE - Emirati Arabi Uniti 20
BE - Belgio 20
NP - Nepal 20
CL - Cile 19
PE - Perù 19
SA - Arabia Saudita 18
CZ - Repubblica Ceca 17
EG - Egitto 17
KZ - Kazakistan 17
TN - Tunisia 17
DZ - Algeria 16
JM - Giamaica 16
PH - Filippine 16
AT - Austria 15
AU - Australia 15
RS - Serbia 13
HN - Honduras 12
LT - Lituania 12
BY - Bielorussia 10
IL - Israele 10
SN - Senegal 10
AO - Angola 9
CH - Svizzera 8
EU - Europa 8
LB - Libano 8
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
GA - Gabon 7
MY - Malesia 7
PT - Portogallo 7
RO - Romania 7
AL - Albania 6
BO - Bolivia 6
CG - Congo 6
ET - Etiopia 6
GE - Georgia 6
GR - Grecia 6
IE - Irlanda 6
KG - Kirghizistan 6
NG - Nigeria 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
QA - Qatar 5
EE - Estonia 4
IR - Iran 4
PA - Panama 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
GT - Guatemala 3
MD - Moldavia 3
MK - Macedonia 3
NI - Nicaragua 3
SI - Slovenia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BW - Botswana 2
GY - Guiana 2
Totale 24.662
Salva come PNG Salva come JPEG
Città #
Dallas 3.996
Singapore 1.443
Chandler 1.222
San Jose 1.003
Jacksonville 671
Hong Kong 585
Ashburn 485
Princeton 415
Beijing 323
Nanjing 256
São Paulo 239
Dearborn 235
Lauterbourg 203
Wilmington 183
Ho Chi Minh City 143
Shanghai 140
Boardman 118
Santa Clara 109
Hanoi 108
Los Angeles 102
Nanchang 97
Rio de Janeiro 91
Ann Arbor 85
Belo Horizonte 84
Tianjin 80
New York 79
Helsinki 71
Woodbridge 65
Shenyang 64
Council Bluffs 62
Brasília 58
Columbus 57
Tokyo 54
Hebei 53
Tashkent 53
Sassari 50
Changsha 47
Curitiba 47
Frankfurt am Main 47
The Dalles 47
Jiaxing 46
Campinas 44
San Francisco 44
Baghdad 39
Izmir 39
Mountain View 37
Warsaw 37
Jinan 35
Norwalk 35
Falls Church 34
Hangzhou 32
Porto Alegre 32
Salvador 32
Zhengzhou 32
Orem 31
Johannesburg 30
Kunming 30
Montreal 30
Seoul 30
Ningbo 29
Andover 28
Atlanta 28
Buffalo 28
Amsterdam 27
Munich 27
Campo Grande 26
Denver 26
Santo André 26
Baku 25
Guarulhos 25
Nairobi 25
São José dos Campos 25
Dhaka 24
Falkenstein 24
London 24
Mexico City 24
Toronto 24
Amman 23
Houston 23
Sorocaba 23
Chennai 22
Goiânia 22
Quito 22
Brooklyn 21
Ribeirão Preto 21
Haiphong 20
Manaus 20
Montevideo 20
Phoenix 20
Recife 20
Stockholm 20
Brussels 19
Caracas 19
Fortaleza 19
Guangzhou 19
Istanbul 18
Jakarta 18
Muscat 18
Cape Town 17
Florianópolis 17
Totale 14.865
Salva come PNG Salva come JPEG
Nome #
Speciation and structural transformation of a VV–malate complex in the absence and in the presence of a protein: from a dinuclear species to decavanadate 288
Controlling intramolecular electronic communication through the conformation changes via stepwise oxidations in dicopper(ii) and dinickel(ii) porphyrin dimers 236
Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases 230
Bioinspired Oxidized Dicobalt Porphyrin Dimer-Catalyzed Cycloaddition Reactions: Cooperative Catalysis and Spectroscopic and Mechanistic Investigation 196
A Multi-Technique Investigation of the Complex Formation Equilibria between Bis-Deferiprone Derivatives and Oxidovanadium (IV) 182
Co-ordination Ability of Cu2+ ion toward the Nucleobase-Amino Acid Willardiine 179
A hexanucluear copper(II) Schiff base complex incorporating rare “bicapped cubane” core: Structural aspects, magnetic properties and EPR study 178
A 2-D coordination polymer incorporating cobalt(II), 2-sulfoterephthalate and the flexible bridging ligand 1,3-di(4-pyridyl)propane 166
5,5′-Dibenzoimidazole as building block for a new 3D Co(II) coordination polymer: A combined EPR and DFT study using UB3LYP model 156
Binding of oxovanadium(IV) to imidazole, pyrazole and thiazole ligands 155
A trigonal prismatic anionic iron(III) complex of a radical o-iminobenzosemiquinonate derivative: Structural and spectral analyses 153
A novel mixed valent CuII–CuI 2D framework made of a hydrazone and μ-SCN bridged metallacyclic loops cross-linked by μ3-SCN chains 152
A novel μ1,1-azido-, μ2-alkoxo-, and μ2-phenoxo-bridged tetranuclear copper(II) complex with a quinquedentate Schiff-base ligand: magneto-structural and DFT studies 152
Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution 149
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 146
A New CuII Coordination Polymer: Structural Elucidation, EPR and Sensing Studies for Detection of Volatile Organic Solvents 146
A rare cobalt(III) paramagnetic derivative incorporating 1-alkyl-2-[(o-thioalkyl)phenylazo]imidazole (SMeaaiNEt): EPR, redox and magnetic interpretation 145
A Ni(II) derivative incorporating tetradentate Schiff base precursor: Structure, spectral, electrochemical and DFT interpretation 145
A mixed valent heterometallic Cu-II/Na-I coordination polymer with sodium–phenyl bonds 144
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH 143
End-to-end thiocyanato-bridged zig-zag polymers of CuII, CoII and NiII with a hydrazone ligand: EPR, magnetic susceptibility and biological study 139
Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin 139
A new linear double phenoxide-bridged trinuclear Cu(II) Schiff base complex: Synthesis, crystallographic elucidation, magneto-structural 138
Covalent and non-covalent binding in vanadium–protein adducts 138
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 138
A Trimetallic Cu(II) Derivative as an Efficient and Stable Electrocatalyst for Reduction of Proton to Molecular Hydrogen 138
A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds 137
Synthesis of Two New Linear Trinuclear CuII Complexes: Mechanism of Magnetic Coupling through Hybrid B3LYP Functional and CShM Studies 137
Binding of VIVO2+ to the Fe binding sites of human serum transferrin. A theoretical study 136
Speciation of potential anti-diabetic vanadium complexes in real serum samples 135
A Ni(II) dinuclear complex bridged by end-on azide-N and phenolate-O atoms: spectral interpretation, magnetism and biological study 135
An enolato-bridged dinuclear Cu(II) complex with a coumarin-assisted precursor: a spectral, magnetic and biological study 133
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 132
Binding of Oxovanadium(IV) to Dipeptides containing Histidine and Cysteine Residues 131
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 131
Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes 130
Synthesis of Nitric Oxide Donors Derived from Piloty’s Acid and Study of Their Effects on Dopamine Secretion from PC12 Cells 130
Formation of Mixed‐Valence Cage‐Like Polyoxidovanadates at 37°C Upon Reaction of VIVO(acetylacetonato)2 With Lysozyme 129
Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state 129
A New phenoxido/trifluoroacetato bridged heterometallic Ni II2 –Cu II derivative: Structure, EPR interpretation and DFT computation 129
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 129
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations 129
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 128
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 127
A new Ni(II) coordination polymer formed by bulky bis(imidazole) and 4,4′-oxybis(benzoic acid): Topological and spectral elucidation 126
Nonoxido VIV complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 126
Binding of potential antitumor Casiopeínas® to small proteins 125
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 125
Simple Coordination Geometry Descriptors Allow to Accurately Predict Metal-Binding Sites in Proteins 125
Oxovanadium(IV) binding to ligands containing donor sites of biological relevance 122
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application 122
Complex formation between [(η6-p-cym)Ru(H2O)3]2+ and oligopeptides containing three histidyl moieties 122
Cobalt(II), manganese(IV) mononuclear and zinc(II) symmetric dinuclear complexes of an aliphatic hydrazone Schiff base ligand with diversity in coordination behaviors and supramolecular architectures: syntheses, structural elucidations, and spectroscopic characterizations 121
Physicochemical, antioxidant, DNA cleaving properties and antimicrobial activity of fisetin-copper chelates 121
VIVO Complexes of Bis(imidazol-2-yl) Derivatives: a Potentiometric, Spectroscopic and DFT Study 120
Vanadium and proteins: Uptake, transport, structure,activity and function 119
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug 119
Synthesis, structure, physicochemical characterization and theoretical evaluation of non-covalent interaction energy of a polymeric copper(II)-hydrazone complex 119
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 118
Bis- and tris(pyridyl)amine-oxidovanadium complexes: characteristics and insulin-mimetic potential 118
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 118
Electronic structure of oxovanadium(IV) complexes of alpha-hydroxycarboxylic acids 117
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 117
Solution speciation and spectral studies on oxovanadium(IV) complexes of pyridinecarboxylic acids 116
Effect of temperature and ligand protonation on the electronic ground state in Cu(ii) polymers having unusual secondary interactions: a magnetic and catechol oxidase study 115
V(IV)O complexes with bis(pyridyl) derivatives 114
A rare doubly nitrato and phenoxido bridged trimetallic CuIIcomplex: EPR, antiferromagnetic coupling and theoretical rationalization 114
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 114
Coordination modes of hydroxamic acids in copper(II), nickel(II) and zinc(II) mixed-ligand complexes in aqueous solution 113
Structural elucidation, EPR and magnetic property of a Co(III) complex salt incorporating 4,4′-bipyridine and 5-sulfoisophthalate 113
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions 113
Electron Shuttling in High-Valent Heterobimetallic NiFe-Porphyrin Dimers: Stabilization of Ni(III) and Fe-Phenoxyl Radicals 112
Determination of the hyperfine coupling constant and zero-field splitting in the ESR spectrum of Mn2+ in calcite 111
New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum 111
Coordination ability and biological activity of a naringenin thiosemicarbazone 111
Role of Ligands in the Uptake and Reduction of V(V) Complexes in Red Blood Cells 111
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 111
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies 111
Interaction of VO2+ ion with human serum transferrin and albumin 111
Interaction of VVO2−hydrazonates with lysozyme 110
Bulky bis(imidazole) and 2-sulfoterephthalate Assisted 3-D Cu(II) and 2-D Mn(II) Coordination Polymers: Topology, Diversity in Metal Containing Nodes and Spectral Elucidation 110
The equilibrium between the octahedral and square pyramidal form in VIVO complexes and the influence of an axial ligand on their molecular properties: a spectroscopic and DFT study 110
Vanadium 109
Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing 109
Synthesis, structural aspects and magnetic properties of an unusual 2D thiocyanato-bridged cobalt(II)-Schiff base network 109
Synthesis and characterization of the chemical properties of new classes of NO donors as potential dopamine releasers in the treatment of Parkinson’s disease 109
Oxovanadium(IV) complexes with pyrazinecarboxylic acids: The coordinating properties of ligands with the (N-aromatic, COO-) donor set 108
Accurate prediction of vertical electronic transitions of Ni(II) coordination compounds via time dependent density functional theory 108
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 108
Ferromagnetic exchange coupling in a new bis(l-chloro)-bridged copper(II) Schiff base complex: synthesis, structure, magnetic properties and catalytic oxidation of cycloalkanes 107
Enhancement of dopamine release induced by new class of nitric oxide donor derived from piloty acid: an in vitro microdialysis study 107
Interaction between the low molecular mass components of blood serum and the VO(IV)-DHP system (DHP=1,2-dimethyl-3-hydroxy-4(1H)-pyridinone) 107
Copper(II) complexes of imidazolinone herbicides 106
The determination of the geometry of Cu(II) complexes - An EPR spectroscopy experiment 106
Interaction of Vanadium(IV) Species with Ubiquitin: A Combined Instrumental and Computational Approach 106
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 106
Chelating properties of EDTA-type ligands containing six-membered backbone ring toward copper ion: Structure, EPR and TD-DFT evaluation 106
Chelating ability and biological activity of hesperetin Schiff base 106
Application of DFT Methods in the Study of (VO2+)-O-IV-Peptide Interactions 106
Ternary complex formation between VO(IV)-picolinic acid or VO(IV)-6-methylpicolinic acid and small blood serum bioligands 106
Totale 12.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022988 132 0 1 13 41 26 47 83 103 54 95 393
2022/20232.201 231 140 45 392 214 388 2 268 380 18 72 51
2023/2024538 122 74 16 37 87 25 8 17 8 5 52 87
2024/20256.599 47 73 374 113 225 244 525 1.312 2.340 866 274 206
2025/202610.465 313 2.232 2.412 1.252 801 588 1.376 300 390 494 262 45
Totale 25.070